Late‐onset and young‐onset relapsing‐remitting multiple sclerosis: evidence from a retrospective long‐term follow‐up study
European Journal of Neurology2018Vol. 25(12), pp. 1425–1431
Citations Over TimeTop 10% of 2018 papers
Emanuele D’Amico, Francesco Patti, Aurora Zanghì, Clara Grazia Chisari, Salvatore Lo Fermo, Mario Zappia
Abstract
The male population with LORRMS reached severe disability faster than those with YORRMS, even when YORRMS showed more brain inflammatory features on MRI.
Related Papers
- → Altered frequency of T regulatory cells is associated with disability status in relapsing–remitting multiple sclerosis patients(2012)38 cited
- → Supporting personalized treatment decisions in relapsing remitting multiple sclerosis (RRMS) (P6.358)(2018)1 cited
- → FP39-WE-03 Long-term immunomodulating treatment in relapsing-remitting multiple sclerosis: how to reduce the number of drop-out patients(2009)
- → Iron Content in Benign and Non-Benign Patients with Relapsing-Remitting Multiple Sclerosis (P06.108)(2013)
- → EE658 Cost-Consequence of Cladribine Tablets for the Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis (RRMS) in the UK(2023)